Skip to main content

Khosla Ventures — Portfolio, Page 16

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

801
Companies
$38.3B
Total invested
$56.1M
Avg. check
70
Industries
Artificial Intelligence (AI) 10Software 7Biotechnology 4Health Care 4Information Technology 4Financial Services 4+64 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 361–384 of 801
Excelsior Sciences
December 2025

Excelsior Sciences applies AI and automated chemistry to simplify small-molecule discovery and accelerate overall drug development.

Artificial Intelligence (AI) · New York$70.0M Series A
Gen1E Lifesciences
December 2025

GEn1E is a clinical-stage multi-target AI platform. They develop novel, next-gen, immunomodulators for rare & inflammatory diseases.

Artificial Intelligence (AI) · Palo Alto$5.5M Venture - Series Unknown
Vinci
December 2025

Vinci utilizes generative artificial intelligence to create hardware design.

Artificial Intelligence (AI) · Palo Alto$36.0M Series A
Ripple Foods
December 2025

Ripple Foods specializes in making non-dairy milk with just as much protein as milk and half the sugar.

Food and Beverage · Berkeley$17.0M Venture - Series Unknown
GoodTrust
December 2021

GoodTrust (MyGoodTrust.com) is an online service offering Smart Estate Planning - Your Will, Trust, Directives and Secure Digital Vault.

Document Management · Palo Alto$5.0M Seed
Peripheral Labs
December 2025

Peripheral Labs brings spatial intelligence to live media.

Information Technology · Toronto$3.6M Seed
Trade Republic
December 2025

Trade Republic helps Europeans for wealth creation through easy, secure, and free access to financial markets.

Consumer · Berlin$1.4B Secondary Market
Imprint
December 2025

Imprint is a co-brand financial platform that designs, configures, and operates financial products in partnership and loyalty experiences.

Finance · New York$150.0M Series D
Draft
December 2021

Draft is a marketing company that provides content marketing, social media content, SEO, and content writing services.

Artificial Intelligence (AI) · Toronto$18.9M Venture - Series Unknown
PolyAI
December 2025

PolyAI develops conversational artificial intelligence software that enables organizations to automate customer service interactions.

Artificial Intelligence (AI) · San Francisco$86.0M Series D
Homebound
December 2025

Homebound is a custom homebuilder that makes building the perfect home simple, transparent and human.

Architecture · Santa Rosa$300.0M Undisclosed
BioAge Labs
January 2026

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Biopharma · Richmond$115.0M Post-IPO Equity
SketchPro Technologies
December 2023

SketchPro Technologies accelerates the design process by leveraging state of the art technology.

Architecture · San Francisco$4.4M Venture - Series Unknown
Formulary Financial
January 2026

Formulary Financial develops solutions that integrate AI and data-driven systems to support fund administration and asset management.

Accounting · New York$4.6M Seed
Culdesac
January 2022

Culdesac designs, builds, and manages walkable communities.

Property Management · Tempe$30.0M Series A
Lattice
January 2022

Lattice is a people success platform that help business leaders develop engaged, high-performing employees, and winning cultures.

Analytics · San FranciscoSeries F
Ghost Autonomy
November 2023

Ghost offers attention-free driving by developing a software solution with AI approaches.

Artificial Intelligence (AI) · Mountain View$5.0M Series E
ClickHouse
January 2026

ClickHouse provides an open-source database system for real-time analytical reporting.

Analytics · Mountain View$400.0M Series D
Synchron
November 2025

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.

Information Technology · Brooklyn$200.0M Series D
Reevo
November 2025

Reevo is an AI-native revenue operating system that integrates marketing, sales, and customer success into a unified platform.

Artificial Intelligence (AI) · Santa Clara$80.0M Series A
Guardant Health
November 2025

Guardant Health is a precision oncology company that uses blood tests, data sets, and analytics to provide treatment to cancer patients.

Biotechnology · Redwood City$350.0M Post-IPO Debt
Vista.ai
January 2026

Vista.ai is an artificial intelligence that offers clinicians to conduct MRI studies.

Artificial Intelligence (AI) · Palo Alto$29.5M Series B
Because Market
November 2021

Because is personal care direct-to-consumer company focused on meeting the needs of older adults.

Consumer Goods · Palo Alto$35.0M Series B
WithCoverage
January 2026

WithCoverage operates as a modern risk management and insurance broking platform targeting fast-growing businesses.

Business Development · New York$42.0M Series B

Where Khosla Ventures invests

Artificial Intelligence (AI)10
Software7
Biotechnology4
Health Care4
Information Technology4
Financial Services4

About Khosla Ventures's portfolio

How many companies has Khosla Ventures invested in?▸

Khosla Ventures has invested in 801 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Khosla Ventures invest in?▸

Khosla Ventures's top investment sectors include Artificial Intelligence (AI), Software, Biotechnology, Health Care, Information Technology. The firm invests across 70 different industry categories.

What is Khosla Ventures's largest investment?▸

Among tracked funding rounds, Trade Republic received $1.4B in a Secondary Market round. Khosla Ventures's total known invested capital is $38.3B.

What is the average investment size for Khosla Ventures?▸

Khosla Ventures's average investment size is $56.1M across its portfolio of 801 companies.

What are Khosla Ventures's most recent investments?▸

Recent Khosla Ventures portfolio additions include Excelsior Sciences, Gen1E Lifesciences, Vinci, Ripple Foods, GoodTrust. These companies were founded in 2020 or later.

Reach the founders behind these 801 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →